NO.1 PHARMACY(SH:600833)2016-04-29 16:00Financial Performance - Operating income increased by 1.69% year-on-year, reaching ¥430,291,778.85[9] - Net profit attributable to shareholders rose by 10.00% to ¥13,233,492.76 compared to the same period last year[9] - Total operating revenue for the current period reached ¥430,291,778.85, a slight increase of 1.3% compared to ¥423,161,076.76 in the previous period[23] - Operating profit increased to ¥16,983,715.38, compared to ¥15,056,121.86, representing a growth of 12.8%[23] - Net profit for the current period was ¥13,233,492.76, up 10.0% from ¥12,030,521.01 in the previous period[23] - Basic and diluted earnings per share improved to ¥0.0593, compared to ¥0.0539 in the previous period[23] Assets and Liabilities - Total assets decreased by 7.47% from the end of the previous year, amounting to ¥1,138,227,648.54[9] - Total assets decreased from CNY 1,230,134,681.83 at the beginning of the year to CNY 1,138,227,648.54 by the end of the period, a decline of approximately 7.5%[16] - Current assets increased slightly from CNY 604,324,503.02 to CNY 617,988,921.73, representing a growth of about 2.8%[16] - Total liabilities decreased from CNY 447,043,748.28 to CNY 419,720,558.98, a decline of about 6.1%[17] - Non-current liabilities decreased from CNY 123,293,373.43 to CNY 97,259,503.00, a reduction of approximately 21.1%[17] - Shareholders' equity decreased from CNY 783,090,933.55 to CNY 718,507,089.56, a decline of about 8.3%[17] Cash Flow - Net cash flow from operating activities decreased by 59.20% to ¥20,649,119.03 compared to the previous year[9] - The total cash inflow from operating activities for Q1 2016 was CNY 509,024,942.61, slightly up from CNY 508,562,157.32 in the previous period[26] - The net cash flow from operating activities decreased to CNY 20,649,119.03, down 59.3% from CNY 50,605,286.81 in the same period last year[26] - The total cash outflow from operating activities was CNY 488,375,823.58, an increase of 6.6% from CNY 457,956,870.51 in the previous period[26] - The cash balance at the end of the period was CNY 219,327,360.32, up from CNY 213,248,239.43 in the previous year[26] Shareholder Information - The number of shareholders reached 22,433 by the end of the reporting period[11] - The largest shareholder, Shanghai Xinduda Commercial (Group) Co., Ltd., holds 23.39% of the shares[11] Other Income and Expenses - Non-operating income rose by 58.67% to ¥167,855.46, primarily from gains on the disposal of non-current assets[12] - Total operating costs amounted to ¥413,308,063.47, up from ¥408,104,954.90, reflecting a 1.5% increase[23] - Sales expenses increased to ¥30,118,453.40 from ¥29,079,561.81, indicating a rise of 3.6%[23] - Management expenses rose to ¥18,257,495.13, compared to ¥16,616,714.27, marking a 9.9% increase[23] - The company reported a financial expense of -¥2,426,359.59, which is an increase in income compared to -¥1,588,798.34 in the previous period[23] Comprehensive Income - Other comprehensive income after tax showed a significant decline to -¥77,817,336.75, compared to ¥50,229,057.46 previously[23] - The total comprehensive income for the current period was -¥64,583,843.99, a decrease from ¥62,259,578.47 in the previous period[23] Prepayments and Inventory - Prepayments increased significantly by 299.35% to ¥7,970,947.01 due to increased advance payments for goods[12] - Inventory decreased from CNY 261,823,423.13 to CNY 233,381,205.47, a reduction of approximately 10.9%[16]